How should HIV vaccine efficacy trials be conducted? Diverse U.S. communities speak out

AIDS Education and Prevention

Volumn 18, Issue 6, 2006, Pages 560-572

  Kegeles, Susan M ^a   Johnson, Mallory O ^a   Strauss, Ronald P ^b   Ralston, Brady ^a   Hays, Robert B ^f   Metzger, David S ^c   McLellan Lemal, Eleanor ^d   MacQueen, Kathleen M ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e FAMILY HEALTH INTERNATIONAL   (United States)

^f CAPS ^*

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; LONG TERM CARE; MALE; MALE HOMOSEXUAL; MEDICAL RESEARCH; UNITED STATES;

ADULT; AGED; AIDS VACCINES; CLINICAL TRIALS; FEMALE; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; TREATMENT OUTCOME; UNITED STATES;

EID: 33845602294     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: 10.1521/aeap.2006.18.6.560     Document Type: Article

References (33)

1. Calarota, S. A., & Weiner, D. B. (2003). Present status of human HIV vaccine development. AIDS, 17, (Suppl. 4), S73-S84.
2. Centers for Disease Control and Prevention. (2000). AnSWR: Analysis Software for Word-based Records Program (Version 3.1) [Computer program].
3. Cho, M. W. (2000). Assessment of HIV vaccine development: past, present, and future. Advances in Pharmacology, 49(5), 263-314.
4. Cornwall, A.,&Jewkes, R. (1995).What is participatory research? Social Science and Medicine, 41, 1667-1676.
5. Emanuel, E. J., Wendler, D., & Grady, C. (2000). What makes clinical research ethical? Journal of the American Medical Association, 283(20), 2701-2711.
6. Galloway, M. R. (1998). The complicated ethics of HIV vaccine trials. South African Medical Journal, 88(10), 1288-1289.
7. Gifford, A. L., Cunningham, W.E., Heslin, K.C., Andersen, R.M., Nakazono, T., Lieu, D.K. et al. (2002). Participation in research and access to experimental treatments by HIV-infected patients. New England Journal of Medicine, 346(18), 1373-1382.
8. Green, L., George, A., Daniel, M., Frankish, C.J., Herbert, C.P., Bowie, W.R., et al. (1995). Study of participatory research in health promotion: review and recommendations for the development of participatory research in health promotion in Canada. Vancouver, British Columbia: Royal Society of Canada.
9. Guenter, D., Esparza, J., & Macklin, R. (2000). Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS). Journal of Medical Ethics, 26(1), 37-43.
10. Halpern, S. D., Metzger, D. S., Berlin, J. A., & Ubel, P. A. (2001). Who will enroll? Predicting participation in a phase II AIDS vaccine trial. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 27(3), 281-288.
11. Hays, R. B., & Kegeles, S. M. (1999). Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(2), 164-171.
12. Heyward, W. L., MacQueen, K. M., & Goldenthal, K. L. (1998). HIV vaccine development and evaluation: Realistic expectations. AIDS Research and Human Retroviruses, 14 (Suppl. 3[3]), S205-S210.
13. Israel, B., Schulz, A., & van Olphen, J. (1998). Review of community-based research: Assisting partnership approaches to improve public health. Annual Review of Public Health, 19, 173-202.
14. Jenkins, R. A., Torugsa, K., Markowitz, L.E., Mason, C.J., Jamroentana, V. Brown, A.E., et al. (2000). Willingness to participate in HIV-1 vaccine trials among young Thai men. Sexually Transmitted Infections, 76(5), 386-392.
15. Johnson, M. O. (1999). Belief of vaccine receipt in HIV vaccine trials: Further cautions. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 21(5), 413-416.
16. Johnson, S. C., & Gerber, J. G. (2000). Advances in HIV/AIDS therapy. Advances in Internal Medicine, 45(1), 1-40.
17. Katz, R. V., Kegeles, S. S., Green, B. L., Kressin, N. R., & Claudio, C. (2003). The Tuskegee Legacy Project: history, preliminary scientific findings, and unanticipated societal benefits. Dental Clinics of North America, 47(1), 1-19.
18. Klein, E., & Ho, R. J. (2000). Challenges in the development of an effective HIV vaccine: current approaches and future directions. Clinical Therapeutics, 22(3), 295-314; discussion 265.
19. Klonoff, E. A., & Landrine, H. (1999). Do blacks believe that HIV/AIDS is a government conspiracy against them? Preventative Medicine, 28(5), 451-457.
20. Koblin, B. A., Avrett, S., Taylor, P. E., & Stevens, C. E. (1997). Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15(2), 165-171.
21. Koblin, B. A., Holte, S., Lenderking, B., & Heagerty, P. (2000). Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 24(5), 451-457.
22. MacQueen, K. M., McLellan, E., Metzger, D.S., Kegeles, S., Strauss, R.P., Scotti, Roseanne, et al. (2001). What is community? An evidence-based definition for participatory public health. American Journal of Public Health, 91(12), 1929-1938.
23. MacQueen, K. M., Vanichseni, S., Kitayaporn, D., Lin, L.S., Buavirat, A., Naiwatanakul, T., et al. (1999). Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 21(3), 243-251.
24. McGrath, J. W., George, K., Svilar, G., Ihler, E., Mafigiri, D. Kabugo, M. et al. (2001). Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 27(4), 381-388.
25. Minkler, M., & Wallerstein, N. (Eds.). (2003). Community-based participatory research for health. San Francisco: Jossey-Bass.
26. Perisse, A. R., Schechter, M., Moreira, R.I., do Lago, R.F., Santoro-Lopes, G., & Harrison, L.H. (2000). Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Projeto Praca Onze Study Group. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 25(5), 459-463.
27. Sengupta, S., Strauss, R.P., DeVellis, R., Quinn, S.C., DeVellis, B., & Ware, W.B. (2000). Factors affecting African-American participation in AIDS research. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 24(3), 275-284.
28. Singleton, R., Jr., & Straits, B. C. (1998). Approaches to social research (3rd ed.). New York: Oxford University Press.
29. Snow, B. (Ed.). (1999). HIV vaccine handbook: Community perspectives on participating in research, advocacy, and progress. Wasington, DC: AIDS Vaccine Advocacy Coalition.
30. Strauss, R. P., Sengupta, S., Kegeles, S., McLellan, E., Metzger, D., Eyre, S. et al. (2001a). Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three U.S. communities. Journal of Acquired Immune Deficiency Syndromes, 26(1), 63-71.
31. Strauss, R. P., Sengupta, S., Quinn, S.C., Goeppinger, J., Spaulding, C., Kegeles, S.M., et al. (2001a). The role of community advisory boards: involving communities in the informed consent process. American Journal of Public Health, 91(12), 1938-1943.
32. Thomas, S. B., & Quinn, S. C. (1991). The Tuskegee Syphilis Study, 1932 to 1972: Implications for HIV education and AIDS risk education programs in the black community. American Journal of Public Health, 81(11), 1498-1505.
33. UNAIDS. (2000). Ethical considerations in HIV preventive vaccine research. Geneva, Switzerland: UNAIDS.